Clinical and Experimental Medicine

Aims & Scope

Clinical and Experimental Medicine (CEM) is a multidisciplinary journal that aims to be a forum of scientific excellence and information exchange in relation to the basic and clinical features of the following fields: hematology, onco-hematology, oncology, virology, immunology, and rheumatology.

The journal publishes reviews and editorials, experimental and preclinical studies, translational research, prospectively designed clinical trials, and epidemiological studies.

Papers containing new clinical or experimental data that are likely to contribute to changes in clinical practice or the way in which a disease is thought about will be given priority due to their immediate importance.

Case reports will be accepted on an exceptional basis only, and their submission is discouraged.

The major criteria for publication are clarity, scientific soundness, and advances in knowledge.

In compliance with the overwhelmingly prevailing request by the international scientific community, and with respect for eco-compatibility issues, CEM is now published exclusively online.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	3.5
2024	3.20

Journal Rank

Year	Value
2024	4827

Journal Citation Indicator

Year	Value
2024	2150

SJR (SCImago Journal Rank)

Year	Value
2024	1.000

Quartile

Year	Value
2024	Q1

h-index

Year	Value
2024	59

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology and Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• Organ-specific manifestations of COVID-19 infection

  Citation: 385

  Authors: Maria, Eleni, Despina, Ioannis, Theodora, Efstathios, Evangelos, Meletios A.

• Sjögren’s syndrome: a systemic autoimmune disease

  Citation: 318

  Authors: Simone, Giacomo, Monica, Matteo, Federica, Giuseppe, Francesco, Francesco

• DNA methylation profiles in cancer diagnosis and therapeutics

  Citation: 293

  Authors: Yunbao, Guohong, Fuling, Bojin, Yirong

• Physical exercise as a tool to help the immune system against COVID-19: an integrative review of the current literature

  Citation: 284

  Authors: Matheus Pelinski, Kimberly Kamila, Matheus Ribeiro, Édina, Renata Calciolari, Débora Tavares

• Emerging treatment strategies for COVID-19 infection

  Citation: 252

  Authors: Maria, Ioannis, Eleni, Despina, Magdalini, Ioannis-Georgios, Theodora, Efstathios, Evangelos, Meletios A.

• MiR-34a inhibits proliferation and migration of breast cancer through down-regulation of Bcl-2 and SIRT1

  Citation: 251

  Authors: Laisheng, Linjin, Jinmei, Jie, Jiaoli, Xiaoming

• Behcet’s disease

  Citation: 202

  Authors: M., N.

• Stephen Paget and the ‘seed and soil’ theory of metastatic dissemination

  Citation: 171

  Authors: D., G., A.

• Citation: 159

  Authors: K., S., A., B., V.

• Systemic lupus erythematosus and ocular involvement: an overview

  Citation: 145

  Authors: Rosanna

---